AstraZeneca signs £25m network deal with BT

Pharmaceutical company AstraZeneca has signed a £25m global network agreement with BT to cover 170 managed connections at 131 sites in 60 countries.

Pharmaceutical company AstraZeneca has signed a £25m global network agreement with BT to cover 170 managed connections at 131 sites in 60 countries.

BT will extend the existing BT-managed global MPLS network in the Europe, Middle East and Africa region and Asia Pacific to 33 new sites in the US and South America to provide a single delivery platform.

The pharmaceutical company said the expanded network will ensure that all employees will have access to real-time information as well as provide a foundation for the convergence of voice, video and other multimedia applications across a single network.

Richard Williams, global chief information officer for AstraZeneca, said, "The service model we have developed will ensure BT services will deliver greater agility, responsiveness and collaboration, which will lead to improved business performance."

Laurie Bowen, managing director commercial and brands at BT global services, said the deal was an example of how global businesses are increasingly reliant on permanent connectivity between a high number of sites around the world.

Read more on IT governance

Start the conversation

Send me notifications when other members comment.

Please create a username to comment.

-ADS BY GOOGLE

SearchCIO

SearchSecurity

SearchNetworking

SearchDataCenter

SearchDataManagement

Close